Filgrastim post-chemotherapy mobilizes more CD34+ cells compared to its use during steady-state haemopoiesis

Bone Marrow Transplant. 1995 Aug;16(2):324-5.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Antigens, CD34 / analysis*
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Granulocyte Colony-Stimulating Factor / pharmacology
  • Hematopoiesis / drug effects
  • Hematopoietic Stem Cells / drug effects*
  • Humans
  • Neoplasms / drug therapy*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology

Substances

  • Antigens, CD34
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Filgrastim